
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Odf1 CRISPR/Cas9 KO Plasmid (h) | sc-405840 | 20 µg | $397.00 |
ODF1 encodes outer dense fiber protein 1 (Odf1), a testis-enriched structural component of sperm tail outer dense fibers that supports axonemal stability and elastic recoil during flagellar beating. Odf1 participates in spermiogenesis and late-stage sperm assembly, contributing to cytoskeletal organization and mechanical integrity of the principal piece. Disruption of ODF1-dependent sperm tail architecture is linked to impaired motility and male factor infertility phenotypes, making it relevant for studying mechanisms of asthenozoospermia and related spermatogenic defects. Its restricted expression profile and specialized function provide a focused model for investigating differentiation-dependent regulation of cytoskeletal proteins in germ cells.
Odf1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the ODF1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the ODF1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the ODF1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Odf1 protein expression.
This CRISPR knockout system enables efficient generation of ODF1-deficient cell models for investigation of Odf1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.